Clinical Trial Update: The Efficacy and Safety of "BST104" (Lonicera Flos Extract) in Mild to Moderate Functional Dyspepsia Subjects [Phase 3]

View source ↗

Summary

Phase 3 trial assessing BST104 (Lonicera Flos Extract) for functional dyspepsia with completed status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Functional Dyspepsia
• Irritable Bowel Syndrome

Drugs mentioned

• BST104 (Lonicera Flos Extract)

Snippet

Sponsor: Seoul National University Bundang Hospital | Conditions: Functional Dyspepsia, Irritable Bowel Syndrome | Phase 3 | Status: COMPLETED